全球DNA合成市场规模、份额、趋势和成长分析报告（2026-2034年）

DNA合成市场预计将从2025年的63.9亿美元成长到2034年的315.3亿美元，2026年至2034年的复合年增长率为19.41%。

由于合成生物学、基因治疗、疫苗研发和诊断等领域的应用不断扩展，全球DNA合成市场正经历显着成长。生物技术的进步和对客製化基因序列日益增长的需求是推动市场扩张的主要因素。研究机构、製药公司和生物技术公司是这项需求成长的主要贡献者。

关键成长要素包括DNA合成成本的降低、自动化技术的进步以及对基因研究的大力投入。基因疗法和细胞疗法的快速发展催生了对高品质合成DNA的强劲需求。此外，政府和私人对生命科学研究的投资也进一步推动了全球市场的发展。

展望未来，由于酵素合成技术和高通量平台的创新，DNA合成市场预计将快速扩张。处理时间的缩短、准确性的提高以及生物安全措施的加强将推动产业成长。随着生物技术的不断发展，DNA合成技术仍将是支撑未来医疗保健和工业生物学的基础技术。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球DNA合成市场：依服务分类

• 市场分析、洞察与预测
• 寡核苷酸合成
• 基因合成

第五章 全球DNA合成市场：依方法划分

• 市场分析、洞察与预测
• 固相合成
• 基于PCR的酶合成
• 基于晶片的合成

第六章 全球DNA合成市场：依应用划分

• 市场分析、洞察与预测
• 研究与开发
• 诊断
• 治疗药物

第七章 全球DNA合成市场：依最终用途划分

• 市场分析、洞察与预测
• 生物製药公司
• 学术研究机构
• 受託研究机构

第八章 全球DNA合成市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Biomatik Corporation
  • Bioneer Corporation
  • Eton Bioscience Inc
  • Eurofins Scientific SE
  • GenScript Biotech Corporation
  • IBA Lifesciences GmbH
  • Integrated DNA Technologies Inc
  • Kaneka Eurogentec SA
  • LGC Biosearch Technologies
  • OriGene Technologies Inc
  • ProMab Biotechnologies Inc
  • ProteoGenix
  • Quintara Biosciences
  • Synbio Technologies
  • Thermo Fisher Scientific Inc

The DNA Synthesis Market size is expected to reach USD 31.53 Billion in 2034 from USD 6.39 Billion (2025) growing at a CAGR of 19.41% during 2026-2034.

The Global DNA Synthesis Market is witnessing significant growth due to increasing applications in synthetic biology, gene therapy, vaccine development, and diagnostics. Advances in biotechnology and the rising demand for customized genetic sequences are driving the expansion of this market. Research institutions, pharmaceutical companies, and biotech firms are major contributors to its growing demand.

Important growth drivers include declining DNA synthesis costs, improvements in automation technologies, and strong investments in genetic research. The rapid development of gene and cell therapies has created a strong need for high-quality synthetic DNA. Additionally, government funding and private investments in life sciences research are further supporting market development globally.

Looking forward, the DNA synthesis market is expected to expand rapidly with innovations in enzymatic synthesis and high-throughput platforms. Faster turnaround times, improved accuracy, and enhanced biosecurity measures will strengthen industry growth. As biotechnology continues to evolve, DNA synthesis will remain a fundamental technology supporting the future of healthcare and industrial biology.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Service

• Oligonucleotide Synthesis
• Gene Synthesis

By Method

• Solid-phase Synthesis
• PCR-based Enzyme Synthesis
• Chip-based Synthesis

By Application

• Research and Development
• Diagnostics
• Therapeutics

By End-Use

• Biopharmaceutical Companies
• Academic & Research Institutes
• Contract Research Organizations

COMPANIES PROFILED

• Biomatik Corporation, Bioneer Corporation, Eton Bioscience Inc, Eurofins Scientific SE, GenScript Biotech Corporation, IBA Lifesciences GmbH, Integrated DNA Technologies Inc, Kaneka Eurogentec SA, LGC Biosearch Technologies, OriGene Technologies Inc, ProMab Biotechnologies Inc, ProteoGenix, Quintara Biosciences, Synbio Technologies, Thermo Fisher Scientific Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL DNA SYNTHESIS MARKET: BY SERVICE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Service
• 4.2. Oligonucleotide Synthesis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Gene Synthesis Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DNA SYNTHESIS MARKET: BY METHOD 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Method
• 5.2. Solid-phase Synthesis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. PCR-based Enzyme Synthesis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Chip-based Synthesis Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DNA SYNTHESIS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Research and Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Therapeutics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL DNA SYNTHESIS MARKET: BY END-USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-use
• 7.2. Biopharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Contract Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL DNA SYNTHESIS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Service
  • 8.2.2 By Method
  • 8.2.3 By Application
  • 8.2.4 By End-use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Service
  • 8.3.2 By Method
  • 8.3.3 By Application
  • 8.3.4 By End-use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Service
  • 8.4.2 By Method
  • 8.4.3 By Application
  • 8.4.4 By End-use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Service
  • 8.5.2 By Method
  • 8.5.3 By Application
  • 8.5.4 By End-use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Service
  • 8.6.2 By Method
  • 8.6.3 By Application
  • 8.6.4 By End-use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL DNA SYNTHESIS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Biomatik Corporation
  • 10.2.2 Bioneer Corporation
  • 10.2.3 Eton Bioscience Inc
  • 10.2.4 Eurofins Scientific SE
  • 10.2.5 GenScript Biotech Corporation
  • 10.2.6 IBA Lifesciences GmbH
  • 10.2.7 Integrated DNA Technologies Inc
  • 10.2.8 Kaneka Eurogentec S.A
  • 10.2.9 LGC Biosearch Technologies
  • 10.2.10 OriGene Technologies Inc
  • 10.2.11 ProMab Biotechnologies Inc
  • 10.2.12 ProteoGenix
  • 10.2.13 Quintara Biosciences
  • 10.2.14 Synbio Technologies
  • 10.2.15 Thermo Fisher Scientific Inc